Withdrawing biologics in non-systemic JIA: what matters to pediatric rheumatologists?

OBJECTIVE: Approximately one third of children with JIA receive biologic therapy, but evidence on biologic therapy withdrawal is lacking. This study aims to increase our understanding of whether and when pediatric rheumatologists postpone a decision to withdraw biologic therapy in children with clin...

Descripción completa

Detalles Bibliográficos
Autores principales: van Til, Janine A., Kip, Michelle M. A., Schatorjé, Ellen J. H., Currie, Gillian, Twilt, Marinka, Benseler, Susanne M., Swart, Joost F., Vastert, Sebastiaan J., Wulffraat, Nico, Yeung, Rae S. M., Groothuis-Oudshoorn, C. G. M. (Karin), Warta, Sanne, Marshall, Deborah A., IJzerman, Maarten J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337208/
https://www.ncbi.nlm.nih.gov/pubmed/37434157
http://dx.doi.org/10.1186/s12969-023-00845-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337208/
https://www.ncbi.nlm.nih.gov/pubmed/37434157
http://dx.doi.org/10.1186/s12969-023-00845-4

Ejemplares similares